Subtype specific expression of radioligand targets in the prospective Real World clinico-pathological register trial BRIDGister
Wirtz R, Friedersdorff F, Barski D, Otto T, Bug R, Veltrup E, Kilic E, Hake R, Eidt S, Waldner M, Grabowski P, Pavel ME, Roggisch J, Koch S, Heidenreich A, Baum RP, Ecke TH (2022)
Publication Type: Conference contribution
Publication year: 2022
Journal
Publisher: ELSEVIER
City/Town: AMSTERDAM
Pages Range: S125-S126
Conference Proceedings Title: EUROPEAN UROLOGY
DOI: 10.1016/s0302-2838(22)00172-5
Authors with CRIS profile
Involved external institutions
STRATIFYER Molecular Pathology GmbH
Germany (DE)
Evangelisches Krankenhaus Königin Elisabeth Herzberge
Germany (DE)
Städtische Kliniken Neuss Lukaskrankenhaus GmbH
Germany (DE)
Klinikum Leverkusen
Germany (DE)
St. Elisabeth-Krankenhaus Köln-Hohenlind
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
HELIOS Kliniken
Germany (DE)
Universitätsklinikum Köln
Germany (DE)
Germany (DE)
Evangelisches Krankenhaus Königin Elisabeth Herzberge
Germany (DE)
Städtische Kliniken Neuss Lukaskrankenhaus GmbH
Germany (DE)
Klinikum Leverkusen
Germany (DE)
St. Elisabeth-Krankenhaus Köln-Hohenlind
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
HELIOS Kliniken
Germany (DE)
Universitätsklinikum Köln
Germany (DE)
How to cite
APA:
Wirtz, R., Friedersdorff, F., Barski, D., Otto, T., Bug, R., Veltrup, E.,... Ecke, T.H. (2022). Subtype specific expression of radioligand targets in the prospective Real World clinico-pathological register trial BRIDGister. In EUROPEAN UROLOGY (pp. S125-S126). AMSTERDAM: ELSEVIER.
MLA:
Wirtz, R., et al. "Subtype specific expression of radioligand targets in the prospective Real World clinico-pathological register trial BRIDGister." Proceedings of the EUROPEAN UROLOGY AMSTERDAM: ELSEVIER, 2022. S125-S126.
BibTeX: Download